GE HealthCare to acquire Sofie Biosciences for $945M

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 06 Oct, 10:38 UTC

The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive drugs used in PET imaging.

businessscience

Sources

• T2GE HealthCare to acquire Sofie Biosciences for $945MBioPharma Dive / Healthcare Dive / MedTech Dive06 Oct, 10:38